You are here: Industry Insights > contract

News List

How do you write a quality agreement? Muhammad Asim Niazi
October 18, 2024
The quality agreement is a highly technical document between the pharma product owner and manufacturing contractor to ensure quality in each process and resultant final product.
Pharma contract placements found to increase 250 percent europeanpharmaceuticalreview
August 09, 2019
Pharma contract placement was found to increase by 250 percent compared to last year, according to figures from a recruitment firm.
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract En-CPhI.cn
May 21, 2019
WuXi Biologics announced that it has entered into a strategic partnership Letter of Intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
Oncobiologics Enters First CDMO Contract contractpharma
June 19, 2018
Oncobiologics has entered into a Master Services Agreement (MSA) with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform-based contract development and manufacturing
Cerus receives $15M government contract biospectrumasia
May 18, 2018
The U.S. Department of Health and Human Services' Office for the Assistant Secretary for Preparedness and Response has awarded an R&D contract to Cerus with a base value of ~$15M and maximum value of ~$201M if all options are exercised.
Pharmaceutical contract manufacturing/contract research market worth $238.3 billion by 2025 cphi-online
June 08, 2017
Expanding market for biosimilars and biobetters is anticipated to pronounce the demand for contract development and manufacturing support.
IriSys Doubles Contract with NCI for Mfg. Clinical Trial Materials contractpharma
April 21, 2017
The contract is for development and production of new therapeutic agents for use in clinical trials supported by NCI
Emergent BioSolutions Signs $53 Million BARDA Contract contractpharma
April 11, 2017
Represents a modification of the current contract with the gov’t agency for the manufacture of botulism antitoxin